Phase 1 trial of intraperitoneal paclitaxel in patients with gastric adenocarcinoma and carcinomatosis or positive cytology.

Brian D Badgwell Naruhiko Ikoma Mariela Blum MurphyXuemei WangJeannelyn EstrellaXiaoqian LiuJitesh KawediaJenny Jing LiPaul MansfieldJaffer A Ajani

Published in: Cancer (2024)

. Neutropenia associated with weekly treatments was common. Peritoneal complete clinical response rates with multimodality therapy including PTX were promising.

Keyphrases

chemotherapy induced
squamous cell carcinoma
fine needle aspiration
high grade
locally advanced
ultrasound guided
stem cells
radiation therapy
cell therapy
bone marrow
replacement therapy